v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2024
Dec. 31, 2025
Cash flows from operating activities              
Net loss $ (37,846) $ (38,000)   $ (90,862) $ (506,005)    
Adjustments to reconcile net loss to net cash used in operating activities              
Depreciation       6,982 10,251    
Amortization of intangible assets       3,060 368,429    
Amortization of right-of-use assets       2,282 3,083    
Amortization of patent license       1,031 0    
Share-based compensation expense       22,261 32,080    
Impairment charges 0 0 $ 15,000 0 15,000 $ 40,000  
Gain on disposal of assets       (48,100) 0    
Accretion of discount on marketable securities, net       (571) (3,905)    
Change in the estimated fair value of contingent consideration 0 0   0 (18,700)    
Deferred income taxes       0 (546)    
Other       806 1,456    
Changes in assets and liabilities              
Accounts receivable, net       (2,875) (3,092)    
Inventory, net       (15,858) 4,842    
Prepaid expenses and other assets       (755) 7,797    
Accounts payable       (7,087) 761    
Accrued expenses       171 (1,396)    
Deferred revenue       1,708 685    
Operating lease liabilities       3,201 (661)    
Other liabilities       6,727 (2,219)    
Net cash used in operating activities       (117,879) (92,140)    
Cash flows from investing activities              
Proceeds from disposal of assets       50,000 0    
Payment for waiver of milestone obligation       (1,900) 0    
Purchases of property and equipment       (5,586) (1,853)    
Purchases of intangible assets       (5,000) (5,000)    
Purchase of patent license       (2,056) 0    
Purchases of investments       (61,165) (183,817)    
Maturities of investments       132,748 280,089    
Net cash provided by investing activities       107,041 89,419    
Cash flows from financing activities              
Proceeds from issuance of common stock from equity plans       3,148 3,428    
Net cash provided by financing activities       3,148 3,428    
Net increase (decrease) in cash, cash equivalents, and restricted cash       (7,690) 707    
Cash, cash equivalents, and restricted cash at beginning of period     $ 57,592 65,259 57,592    
Cash, cash equivalents, and restricted cash at end of period 57,569 58,299   57,569 58,299 57,592  
Cash and cash equivalents at end of period 55,907 56,467   55,907 56,467   $ 63,707
Restricted cash at end of period 1,662 1,832   1,662 1,832    
Cash, cash equivalents, and restricted cash at end of period $ 57,569 $ 58,299   57,569 58,299 $ 57,592 $ 65,259
Supplemental disclosure of non-cash investing and financing activities              
Right-of-use asset and lease liability recognized due to lease extension       $ 0 $ 29,575